EX-21.1 2 mrkr-20201231xex21d1.htm EXHIBIT 21.1

Exhibit 21.1

SUBSIDIARIES

​

Marker Cell Therapy, Inc.

​

GeneMax Pharmaceuticals, Inc.

​

GeneMax Pharmaceuticals Canada, Inc.